THE COOK GROUP INC. lobbying for THE COOK GROUP INC.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Expenses

$200,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Lobbyists on this filing 1

ALLISON HOBBS GILES

Previously held: Vice President of Global Government Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 10

HR 4731
Resident Physician Shortage Reduction Act of 2025
HR 4445
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
HR 1539
Medical Device Electronic Labeling Act
HR 1103
New Markets Tax Credit Extension Act of 2025
S 1272
Trade Review Act of 2025
HR 2665
Trade Review Act of 2025
HR 4312
SCORE Act
S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
HR 1153
Rural Physician Workforce Production Act of 2025

Lobbying activity 8

Health Issues

Graduate Medical Education (GME): -"Resident Physician Shortage Reduction Act of 2025" (H.R. 4731) which would increase GME positions in rural areas; -the "Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.

Taxation/Internal Revenue Code

Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)

Housing

USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development

Education

Workforce Development

Tariff (miscellaneous tariff bills)

Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)

Sports/Athletics

Name, Image and Likeness (NIL) issue: "SCORE Act" (H.R. 4312)

Medicare/Medicaid

Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, "Rural Physician Workforce Production Act of 2025" (H.R. 1153)

Chemicals/Chemical Industry

PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices